Announcements
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
- IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
- IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market
More ▼
Key statistics
On Tuesday, IMCD NV (0QVU:LSE) closed at 142.20, -15.83% below its 52-week high of 168.95, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 145.03 |
---|---|
High | -- |
Low | -- |
Bid | 138.95 |
Offer | 146.05 |
Previous close | 143.58 |
Average volume | 59.85k |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 28.06 |
Market cap | 8.21bn EUR |
EPS (TTM) | 5.13 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.56% |
Div ex-date | Apr 28 2023 |
Div pay-date | May 04 2023 |
Next div ex-date | May 16 2024 |
Next div pay-date | May 21 2024 |
Data delayed at least 20 minutes, as of Apr 30 2024 17:13 BST.
More ▼